HUNTERDON  HUNT SETS DENTAL VENTURE YARDLEY PENN MARCH 4 HUNTERDON PHARMACEUTICALS INC SAID IT FORMED A JOINT VENTURE WITH  CHESAPEAKE BIOLOGICAL LABORATORIES AND  EB MICHAELS RESEARCH ASSOCIATES TO DEVELOP C31G A SUBSTANCE THAT MAY BE USEFUL IN THE TREATMENT OR PREVENTION OF PLAQUE THE SUBSTANCE TESTED IN PRE CLINICAL TRIALS AT THE UNIVERSITY OF PENNSYLVANIA ALSO HAS OTHER USES AS AN ANTI FUNGAL OR ANTI BACTERIAL AGENT THE COMPANY SAID IT SAID CHESAPEAKE BIOLOGICAL A PRIVATE COMPANY OWNS 55 PCT OF THE VENTURE EB MICHAELS 10 PCT WHILE IT HOLDS THE REMAINING INTEREST AND THE PATENT FOR C31G   